GE
Generate Biomedicines, Inc. (GENB)
NASDAQ·Healthcare·Biotechnology
$14.96
+12.94%
Mkt Cap $1.59B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$26.00
Range $22.00 – $30.00
Implied Upside
+73.8%
Consensus $26.00 vs current $14.96
NASDAQ·Healthcare·Biotechnology
$14.96
+12.94%
Mkt Cap $1.59B
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$26.00
Range $22.00 – $30.00
+73.8%
Consensus $26.00 vs current $14.96